Improvement of diagnostic agreement among pathologists in resolving an "atypical glands suspicious for cancer" diagnosis in prostate biopsies using a novel "Disease-Focused Diagnostic Review" quality improvement process.
暂无分享,去创建一个
Gioacchino Leandro | R. Shah | G. Leandro | J. Bentley | Wei Tian | Rajal B Shah | Savvas Mendrinos | Wei Tian | R. Lash | Gloria Romerocaces | James Bentley | Jiyoon Yoon | Yousef Tadros | Richard Lash | Y. Tadros | Savvas E Mendrinos | Jiyoon Yoon | Gloria Romerocaces
[1] A. Abdollahi,et al. Inter-observer reproducibility before and after web-based education in the Gleason grading of the prostate adenocarcinoma among the Iranian pathologists. , 2014, Acta medica Iranica.
[2] M. Rugge,et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading , 2002, Alimentary pharmacology & therapeutics.
[3] Athanase Billis,et al. The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies. , 2008, The Journal of urology.
[4] A. Chinnaiyan,et al. Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies. , 2012, Archives of pathology & laboratory medicine.
[5] D. Wilkinson,et al. Equivocal or Ambiguous Terminologies in Pathology: Focus of Continuous Quality Improvement? , 2013, The American journal of surgical pathology.
[6] Rodolfo Montironi,et al. Variability in Diagnostic Opinion Among Pathologists for Single Small Atypical Foci in Prostate Biopsies , 2010, The American journal of surgical pathology.
[7] P. Humphrey,et al. Minimal carcinoma in prostate needle biopsy specimens: diagnostic features and radical prostatectomy follow-up. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[8] J. Hicks,et al. Cytoplasmic PTEN Protein Loss Distinguishes Intraductal Carcinoma of the Prostate from High Grade Prostatic Intraepithelial Neoplasia , 2012, Modern Pathology.
[9] D. Bostwick,et al. Criteria for biopsy diagnosis of minimal volume prostatic adenocarcinoma: analytic comparison with nondiagnostic but suspicious atypical small acinar proliferation. , 2009, Archives of pathology & laboratory medicine.
[10] D. Bostwick,et al. Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: clinical significance in 33 cases. , 1997, The American journal of surgical pathology.
[11] R. Shah,et al. Utility of PTEN and ERG Immunostaining for Distinguishing High-grade PIN From Intraductal Carcinoma of the Prostate on Needle Biopsy , 2015, The American journal of surgical pathology.
[12] J. Epstein,et al. Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy. , 1995, Human pathology.
[13] P. Humphrey,et al. Diagnosis of adenocarcinoma in prostate needle biopsy tissue , 2007, Journal of Clinical Pathology.
[14] Lars Egevad,et al. The reasons behind variation in Gleason grading of prostatic biopsies: areas of agreement and misconception among 266 European pathologists , 2014, Histopathology.
[15] L. Egevad,et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2005, The American journal of surgical pathology.
[16] W. Frable,et al. Surgical pathology--second reviews, institutional reviews, audits, and correlations: what's out there? Error or diagnostic variation? , 2006, Archives of pathology & laboratory medicine.
[17] R. Shah,et al. ETS Gene Aberrations in Atypical Cribriform Lesions of the Prostate: Implications for the Distinction Between Intraductal Carcinoma of the Prostate and Cribriform High-grade Prostatic Intraepithelial Neoplasia , 2010, The American journal of surgical pathology.
[18] J W Arends,et al. Efforts to improve interobserver agreement in histopathological grading. , 1995, Journal of clinical epidemiology.
[19] R. Shah,et al. The diagnostic use of ERG in resolving an "atypical glands suspicious for cancer" diagnosis in prostate biopsies beyond that provided by basal cell and α-methylacyl-CoA-racemase markers. , 2013, Human pathology.
[20] R. Shah. Clinical Applications of Novel ERG Immunohistochemistry in Prostate Cancer Diagnosis and Management , 2013, Advances in anatomic pathology.
[21] Murali Varma,et al. Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle biopsy specimens. A study of 250 consecutive cases in a routine surgical pathology practice. , 2002, Archives of pathology & laboratory medicine.